Lysophosphatidic acid 2 alleviates deep vein thrombosis via protective endothelial barrier function.

Ruifeng Bai, Xinyang Yue, Xuan Tian, Huiru Zhao, Ying Liu, Tian Li, Jun Wu

Abstract read

In one paragraph

Article in Open medicine (Warsaw, Poland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruifeng BaiDepartment of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China.

Xinyang YueDepartment of Clinical Laboratory, Peking University Fourth School of Clinical Medicine, Beijing, 100035, China.

Xuan TianDepartment of Vascular Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China.

Huiru ZhaoDepartment of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China.

Ying LiuBlood Transfusion Department, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China.

Tian LiTianjin Key Laboratory of Acute Abdomen Disease-Associated Organ Injury and ITCWM Repair, Institute of Integrative Medicine of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin 300100, China.

Jun WuDepartment of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, 31 Xinjiekou East St., Beijing, 100035, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The specific role of lysophosphatidic acid 2 (LPA Methods: An inferior vena cava annulus retraction model of DVT was established in wild-type (WT) and global LPA Results: Conclusion: These data provide a novel mechanism of endothelial barrier protection of LPA

Indexed as

deep vein thrombosisendothelial cellslysophosphatidic acid 2vascular endothelial permeabilityzonula occludens-1

Identifiers

PMID39927163

DOI10.1515/med-2024-1137

PMCPMC11806235

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.